within Pharmacolibrary.Drugs.ATC.D;

model D01AE13
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D01AE13</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Selenium sulfide is an inorganic compound used primarily as a topical antifungal agent in the treatment of dandruff and seborrheic dermatitis of the scalp. It is also occasionally used for tinea versicolor. Selenium sulfide is approved for over-the-counter and prescription use in many countries.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic parameters for selenium sulfide in humans have been reported in the literature. Due to its topical use and minimal systemic absorption, pharmacokinetic modeling data such as volume of distribution and clearance are not available.</p><h4>References</h4><ol><li><p>Abdel-Rahman, SM, &amp; Nahata, MC (1997). Treatment of tinea capitis. <i>The Annals of pharmacotherapy</i> 31(3) 338–348. DOI:<a href=\"https://doi.org/10.1177/106002809703100313\">10.1177/106002809703100313</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9066943/\">https://pubmed.ncbi.nlm.nih.gov/9066943</a></p></li><li><p>Sánchez, JL, &amp; Torres, VM (1984). Selenium sulfide in tinea versicolor: blood and urine levels. <i>Journal of the American Academy of Dermatology</i> 11(2 Pt 1) 238–241. DOI:<a href=\"https://doi.org/10.1016/s0190-9622(84)70156-3\">10.1016/s0190-9622(84)70156-3</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6480923/\">https://pubmed.ncbi.nlm.nih.gov/6480923</a></p></li><li><p>Pomeranz, AJ, &amp; Sabnis, SS (2002). Tinea capitis: epidemiology, diagnosis and management strategies. <i>Paediatric drugs</i> 4(12) 779–783. DOI:<a href=\"https://doi.org/10.2165/00128072-200204120-00002\">10.2165/00128072-200204120-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12431130/\">https://pubmed.ncbi.nlm.nih.gov/12431130</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D01AE13;
